Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI114185

Proteolytic inactivation of plasma C1- inhibitor in sepsis.

J H Nuijens, A J Eerenberg-Belmer, C C Huijbregts, W O Schreuder, R J Felt-Bersma, J J Abbink, L G Thijs, and C E Hack

Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.

Find articles by Nuijens, J. in: PubMed | Google Scholar

Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.

Find articles by Eerenberg-Belmer, A. in: PubMed | Google Scholar

Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.

Find articles by Huijbregts, C. in: PubMed | Google Scholar

Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.

Find articles by Schreuder, W. in: PubMed | Google Scholar

Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.

Find articles by Felt-Bersma, R. in: PubMed | Google Scholar

Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.

Find articles by Abbink, J. in: PubMed | Google Scholar

Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.

Find articles by Thijs, L. in: PubMed | Google Scholar

Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.

Find articles by Hack, C. in: PubMed | Google Scholar

Published August 1, 1989 - More info

Published in Volume 84, Issue 2 on August 1, 1989
J Clin Invest. 1989;84(2):443–450. https://doi.org/10.1172/JCI114185.
© 1989 The American Society for Clinical Investigation
Published August 1, 1989 - Version history
View PDF
Abstract

Activation of both the complement system and the contact system of intrinsic coagulation is implicated in the pathophysiology of sepsis. Because C1 inhibitor (C1-Inh) regulates the activation of both cascade systems, we studied the characteristics of plasma C1-Inh in 48 patients with severe sepsis on admission to the Intensive Care Unit at the Free University of Amsterdam. The ratio between the level of functional and antigenic C1-Inh (functional index) was significantly reduced in the patients with sepsis compared with healthy volunteers (P = 0.004). The assessment of modified (cleaved), inactive C1-Inh (iC1-Inh), and complexed forms of C1-Inh (nonfunctional C1-Inh species) revealed that the reduced functional index was mainly due to the presence of iC1-Inh. On SDS-PAGE, iC1-Inh species migrated with a lower apparent molecular weight (Mr 98,000, 91,000, and 86,000) than native C1-Inh (Mr 110,000). Elevated iC1-Inh levels (greater than or equal to 0.13 microM) were found in 81% of all patients, sometimes up to 1.6 microM. Levels of iC1-Inh on admission appeared to be of prognostic value: iC1-Inh was higher in 27 patients who died than in 21 patients who survived (P = 0.003). The mortality in 15 patients with iC1-Inh levels up to 0.2 microM was 27%, but in 12 patients with plasma iC1-Inh exceeding 0.44 microM, the mortality was 83%. The overall mortality in the patients with sepsis was 56%. We propose that the cleavage of C1-Inh in patients with sepsis reflects processes that play a major role in the development of fatal complications during sepsis.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 443
page 443
icon of scanned page 444
page 444
icon of scanned page 445
page 445
icon of scanned page 446
page 446
icon of scanned page 447
page 447
icon of scanned page 448
page 448
icon of scanned page 449
page 449
icon of scanned page 450
page 450
Version history
  • Version 1 (August 1, 1989): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts